North Growth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
North Growth Management's WST Position: Q3 2026 in Review
North Growth Management increased its West Pharmaceutical (WST) stake by 1.6% in Q3 2026, buying an estimated $353K and bringing the position to 63,000 shares worth $23.5M. The position accounts for 3.16% of the portfolio, ranked #11.
North Growth Management first reported a position in WST in Q1 2023 and has held it in 15 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- North Growth Management held 63,000 shares of West Pharmaceutical worth $23.5M as of Q3 2026.
- North Growth Management bought 1,000 West Pharmaceutical shares in Q3 2026, an estimated $353K.
- West Pharmaceutical made up 3.16% of North Growth Management's portfolio in Q3 2026, its #11 holding.
- North Growth Management first reported a position in West Pharmaceutical in Q1 2023 and has held it in 15 quarters since.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on North Growth Management's 13F filing for Q3 2026, filed 20 Oct 2026.